Literature DB >> 29891727

A Rare Variant P507L in TPP1 Interrupts TPP1-TIN2 Interaction, Influences Telomere Length, and Confers Colorectal Cancer Risk in Chinese Population.

Jiaoyuan Li1, Jiang Chang1, Jianbo Tian1, Juntao Ke1, Ying Zhu1, Yang Yang1, Yajie Gong1, Danyi Zou1, Xiating Peng1, Nan Yang1, Shufang Mei1, Xiaoyang Wang1, Liming Cheng2, Weiguo Hu3, Jing Gong1, Rong Zhong1, Xiaoping Miao4.   

Abstract

Background: Telomere dysfunction triggers cellular senescence and constitutes a driving force for cancer initiation. Genetic variants in genes involved in telomere maintenance may contribute to colorectal cancer susceptibility.
Methods: In this study, we firstly captured germline mutations in 192 patients with colorectal cancer by sequencing the coding regions of 13 core components implicated in telomere biology. Five potential functional variants were then genotyped and assessed in a case-control set with 3,761 colorectal cancer cases and 3,839 healthy controls. The promising association was replicated in additional 6,765 cases and 6,906 controls. Functional experiments were used to further clarify the potential function of the significant variant and uncover the underlying mechanism in colorectal cancer development.
Results: The two-stage association studies showed that a rare missense variant rs149418249 (c.C1520T and p.P507L) in the 11th exon of TPP1 (also known as ACD, gene ID 65057) was significantly associated with colorectal cancer risk with the ORs being 2.90 [95% confidence interval (CI), 1.04-8.07; P = 0.041], 2.50 (95% CI, 1.04-6.04; P = 0.042), and 2.66 (95% CI, 1.36-5.18; P = 0.004) in discovery, replication, and the combined samples, respectively. Further functional annotation indicated that the TPP1 P507L substitution interrupted TPP1-TIN2 interaction, impaired telomerase processivity, and shortened telomere length, which subsequently facilitated cell proliferation and promoted colorectal cancer development.Conclusions: A rare variant P507L in TPP1 confers increased risk of colorectal cancer through interrupting TPP1-TIN2 interaction, impairing telomerase processivity, and shrinking telomere length.Impact: These findings emphasize the important role of telomere dysfunction in colorectal cancer development, and provide new insights about the prevention of this type of cancer. Cancer Epidemiol Biomarkers Prev; 27(9); 1029-35. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29891727     DOI: 10.1158/1055-9965.EPI-18-0099

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  18 in total

Review 1.  Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk.

Authors:  Amal Ahmed Abd El-Fattah; Nermin Abdel Hamid Sadik; Olfat Gamil Shaker; Amal Mohamed Kamal
Journal:  Mediators Inflamm       Date:  2018-10-25       Impact factor: 4.711

2.  Association of circulating leukocyte telomere length with survival in patients with colorectal cancer.

Authors:  Svenja Pauleck; Biljana Gigic; Richard M Cawthon; Jennifer Ose; Anita R Peoples; Christy A Warby; Jennifer A Sinnott; Tengda Lin; Juergen Boehm; Petra Schrotz-King; Christopher I Li; David Shibata; Erin M Siegel; Jane C Figueiredo; Adetunji T Toriola; Martin Schneider; Alexis B Ulrich; Albrecht Hoffmeister; Cornelia M Ulrich; Sheetal Hardikar
Journal:  J Geriatr Oncol       Date:  2022-01-05       Impact factor: 3.929

Review 3.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

4.  Identification of key gene signatures for the overall survival of ovarian cancer.

Authors:  Akash Pawar; Oindrila Roy Chowdhury; Ruby Chauhan; Sanjay Talole; Atanu Bhattacharjee
Journal:  J Ovarian Res       Date:  2022-01-20       Impact factor: 4.234

5.  LMO1 Gene Polymorphisms Reduce Neuroblastoma Risk in Eastern Chinese Children: A Three-Center Case-Control Study.

Authors:  Lili He; Jinhong Zhu; Fei Han; Yingzi Tang; Chunlei Zhou; Jincheng Dai; Yizhen Wang; Haixia Zhou; Jing He; Haiyan Wu
Journal:  Front Oncol       Date:  2018-10-23       Impact factor: 6.244

6.  NRAS and KRAS polymorphisms are not associated with hepatoblastoma susceptibility in Chinese children.

Authors:  Tianyou Yang; Yang Wen; Jiahao Li; Tianbao Tan; Jiliang Yang; Jing Pan; Chao Hu; Yuxiao Yao; Jiao Zhang; Yijuan Xin; Suhong Li; Huimin Xia; Jing He; Yan Zou
Journal:  Exp Hematol Oncol       Date:  2019-05-09

7.  Additional data support the role of LINC00673 rs11655237 C>T in the development of neuroblastoma.

Authors:  Yong Li; Zhen-Jian Zhuo; Haiyan Zhou; Jiabin Liu; Zan Liu; Jiao Zhang; Jiwen Cheng; Suhong Li; Haixia Zhou; Rong Zhou; Jing He; Yaowang Zhao
Journal:  Aging (Albany NY)       Date:  2019-04-20       Impact factor: 5.682

8.  LINC00673 rs11655237 Polymorphism Is Associated With Increased Risk of Cervical Cancer in a Chinese Population.

Authors:  Yanhua Wang; Tianyou Luo
Journal:  Cancer Control       Date:  2018 Jan-Dec       Impact factor: 3.302

9.  XRCC1 gene polymorphisms and risk of neuroblastoma in Chinese children.

Authors:  Jiao Zhang; Zhenjian Zhuo; Wenya Li; Jinhong Zhu; Jing He; Jinsong Su
Journal:  Aging (Albany NY)       Date:  2018-10-25       Impact factor: 5.682

10.  Association between NER Pathway Gene Polymorphisms and Wilms Tumor Risk.

Authors:  Jinhong Zhu; Wen Fu; Wei Jia; Huimin Xia; Guo-Chang Liu; Jing He
Journal:  Mol Ther Nucleic Acids       Date:  2018-08-08       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.